Montserrat Carmona

Dr. Montserrat Carmona

Health Technology Assessment Agency, Instituto de Salud Carlos III, Madrid, Spain
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Journal of Cardiopulmonary Rehabilitation and Prevention
Verified
Journal Article
Closed access
ABAna Blasco-Lobo
Ana Blasco-Lobo
MCMontserrat Carmona
Montserrat Carmona
IFIgnacio Fernández-Lozano
Ignacio Fernández-Lozano
CSCarlos H. Salvador
Carlos H. Salvador
MCMario Pascual Carrasco
Mario Pascual Carrasco
LALuis Alonso-Pulpón
Luis Alonso-Pulpón
Efficient ways are needed to implement the secondary prevention (SP) of coronary heart disease. Because few studies have investigated Web-based SP programs, our aim was to determine the usefulness of a new Web-based telemonitoring system, connecting patients provided with self-measurement devices and care managers via mobile phone text messages, as a tool for SP. A single-blind, randomized controlled, clinical trial of 203 acute coronary syndrome (ACS) survivors, was conducted at a hospital in Madrid, Spain. All patients received lifestyle counseling and usual-care treatment. Patients in the telemonitoring group (TMG) sent, through mobile phones, weight, heart rate, and blood pressure (BP) weekly, and capillary plasma lipid profile and glucose monthly. A cardiologist accessed these data through a Web interface and sent recommendations via short message service. Main outcome measures were BP, body mass index (BMI), smoking status, low-density lipoprotein-cholesterol (LDL-c), and glycated hemoglobin A₁c (HbA₁c). At 12-month followup, TMG patients were more likely (RR = 1.4; 95% CI = 1.1-1.7) to experience improvement in cardiovascular risk factors profile than control patients (69.6% vs 50.5%, P = .010). More TMG patients achieved treatment goals for BP (62.1% vs 42.9%, P = .012) and HbA₁c (86.4% vs 54.2%, P = .018), with no differences in smoking cessation or LDL-c. Body mass index was significantly lower in TMG (-0.77 kg/m² vs +0.29 kg/m², P = .005). A telemonitoring program, via mobile phone messages, appears to be useful for improving the risk profile in ACS survivors and can be an effective tool for secondary prevention, especially for overweight patients.

16 February 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LGLuis García-Olmos
Luis García-Olmos
CSCarlos H Salvador
Carlos H Salvador
ÁAÁngel Alberquilla
Ángel Alberquilla
DLDavid Lora
David Lora
MCMontserrat Carmona
Montserrat Carmona
FGFernando García-López
Fernando García-López
Healthcare management is oriented toward single diseases, yet multimorbidity is nevertheless the rule and there is a tendency for certain diseases to occur in clusters. This study sought to identify comorbidity patterns in patients with chronic diseases, by reference to number of comorbidities, age and sex, in a population receiving medical care from 129 general practitioners in Spain, in 2007. A cross-sectional study was conducted in a health-area setting of the Madrid Autonomous Region (Comunidad Autónoma), covering a population of 198,670 individuals aged over 14 years. Multiple correspondences were analyzed to identify the clustering patterns of the conditions targeted. Forty-two percent (95% confidence interval [CI]: 41.8–42.2) of the registered population had at least one chronic condition. In all, 24.5% (95% CI: 24.3–24.6) of the population presented with multimorbidity. In the correspondence analysis, 98.3% of the total information was accounted for by three dimensions. The following four, age- and sex-related comorbidity patterns were identified: pattern B, showing a high comorbidity rate; pattern C, showing a low comorbidity rate; and two patterns, A and D, showing intermediate comorbidity rates. Four comorbidity patterns could be identified which grouped diseases as follows: one showing diseases with a high comorbidity burden; one showing diseases with a low comorbidity burden; and two showing diseases with an intermediate comorbidity burden.

16 January 2013 in BMC Family Practice
Verified
Journal Article
Open access
PDF file
LGLuis García-Olmos
Luis García-Olmos
ÁAÁngel Alberquilla
Ángel Alberquilla
VAVictoria Ayala
Victoria Ayala
PGPilar García-Sagredo
Pilar García-Sagredo
LMLeticia Morales
Leticia Morales
JMJose L Monteagudo
Jose L Monteagudo
Chronic obstructive pulmonary disease (COPD) is frequent and often coexists with other diseases. The aim of this study was to quantify the prevalence of COPD and related chronic comorbidity among patients aged over 40 years visiting family practices in an area of Madrid.

14 November 2022 in European Journal of Neurology
Verified
Journal Article
Closed access
BLBeatriz León‐Salas
Beatriz León‐Salas
YGYadira González‐Hernández
Yadira González‐Hernández
DIDiego Infante-Ventura
Diego Infante-Ventura
AAAythami de Armas‐Castellano
Aythami de Armas‐Castellano
JGJavier García‐García
Javier García‐García
MTMaría M. Trujillo‐Martín
María M. Trujillo‐Martín

1 March 2020 in Journal of Vascular Surgery: Venous and Lymphatic Disorders
Verified
Journal Article
Closed access
EGEsther García-Carpintero
Esther García-Carpintero
MCMontserrat Carmona
Montserrat Carmona
JCJuan Pablo Chalco-Orrego
Juan Pablo Chalco-Orrego
JGJesús González-Enríquez
Jesús González-Enríquez
IIIñaki Imaz-Iglesia
Iñaki Imaz-Iglesia

2 November 2020 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
YRYolanda Ramallo-Fariña
Yolanda Ramallo-Fariña
MGMiguel A. García-Bello
Miguel A. García-Bello
LGLidia García-Pérez
Lidia García-Pérez
MBMauro Boronat
Mauro Boronat
AWAna M Wägner
Ana M Wägner
ITIndica Team
Indica Team
Background: Type 2 diabetes mellitus (T2DM) is a chronic disease in which health outcomes are related to decision making by patients and health care professionals. Objective: This study aims to assess the effectiveness of internet-based multicomponent interventions to support decision making of all actors involved in the care of patients with T2DM in primary care. Methods: The INDICA study is an open, community-based, multicenter trial with random allocation to usual care or the intervention for patients, the intervention for health care professionals in primary care, or the combined intervention for both. In the intervention for patients, participants received an educational group program and were monitored and supported by logs, a web-based platform, and automated SMS. Those in the intervention for professionals also received an educational program, a decision support tool embedded in the electronic clinical record, and periodic feedback about patients’ results. A total of 2334 people with T2DM, regardless of glycated hemoglobin (HbA1c) levels and without diabetes-related complications, were included. The primary end point was change in HbA1c level. The main analysis was performed using multilevel mixed models. Results: For the overall sample, the intervention for patients attained a significant mean reduction in HbA1c levels of ‒0.27 (95% CI ‒0.45 to ‒0.10) at month 3 and ‒0.26 (95% CI ‒0.44 to ‒0.08) at month 6 compared with usual care, which remained marginally significant at month 12. A clinically relevant reduction in HbA1c level was observed in 35.6% (191/537) of patients in the intervention for patients and 26.0% (152/586) of those in usual care at month 12 (P=.006). In the combined intervention, HbA1c reduction was significant until month 18 (181/557, 32.6% vs 140/586, 23.9%; P=.009). Considering the subgroup of patients uncontrolled at baseline, all interventions produced significant reductions in HbA1c levels across the entire study period: ‒0.49 (95% CI ‒0.70 to ‒0.27) for the intervention for patients, ‒0.35 (95% CI ‒0.59 to ‒0.14) for the intervention for professionals, and ‒0.35 (95% CI ‒0.57 to ‒0.13) for the combined intervention. Differences in HbA1c for the area under the curve considering the entire period were significant for the intervention for patients and the combined intervention compared with usual care (P=.03 for both). Compared with usual care, the intervention for professionals and the combined intervention had significant longer-term reductions in systolic and diastolic blood pressure. Conclusions: In uncontrolled patients, the intervention for patients at baseline provided clinically relevant and significant longer-term reductions of HbA1c levels. The intervention for professionals and combined intervention also improved the cardiovascular risk profile of patients. Trial Registration: ClinicalTrials.gov NCT01657227; https://clinicaltrials.gov/ct2/show/NCT01657227